These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36568125)

  • 1. Leadership in a pandemic: Do more able managers keep firms out of trouble?
    Nguyen HT; Pham MH; Truong C
    J Behav Exp Finance; 2023 Mar; 37():100781. PubMed ID: 36568125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19, ESG investing, and the resilience of more sustainable stocks: Evidence from European firms.
    Cardillo G; Bendinelli E; Torluccio G
    Bus Strategy Environ; 2022 Jun; ():. PubMed ID: 35942337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Firm performance during the Covid-19 crisis: Does managerial ability matter?
    Kumar S; Zbib L
    Financ Res Lett; 2022 Jun; 47():102720. PubMed ID: 35177959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can R&D investment reduce the impact of COVID-19 on firm performance?-Evidence from India.
    Biswas S
    J Public Aff; 2021 Oct; ():e2773. PubMed ID: 34899063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corporate immunity to the COVID-19 pandemic.
    Ding W; Levine R; Lin C; Xie W
    J financ econ; 2021 Aug; 141(2):802-830. PubMed ID: 34580557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Financing constraints and firm-level responses to the COVID-19 pandemic: International evidence.
    Khan SU
    Res Int Bus Finance; 2022 Jan; 59():101545. PubMed ID: 34580554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Green management, access to credit, and firms' vulnerability to the COVID-19 crisis.
    Aristei D; Gallo M
    Small Bus Econ (Dordr); 2023 Apr; ():1-33. PubMed ID: 38625207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The COVID-19 pandemic and family business performance.
    Miroshnychenko I; Vocalelli G; De Massis A; Grassi S; Ravazzolo F
    Small Bus Econ (Dordr); 2023 Apr; ():1-29. PubMed ID: 38625269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corporate social performance and firm debt levels: Impacts of the covid-19 pandemic and institutional environments.
    Bai M; Ho L
    Financ Res Lett; 2022 Jun; 47():102968. PubMed ID: 35578609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Firms' COVID-19 Pandemic Exposure and Corporate Cash Policy: Evidence from China.
    He Z; Suardi S; Wang K; Zhao Y
    Econ Model; 2022 Nov; 116():105999. PubMed ID: 36032988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the COVID-19 pandemic: Evidence from the U.S. restaurant industry.
    Song HJ; Yeon J; Lee S
    Int J Hosp Manag; 2021 Jan; 92():102702. PubMed ID: 33024347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small firms and the COVID-19 insolvency gap.
    Dörr JO; Licht G; Murmann S
    Small Bus Econ (Dordr); 2022; 58(2):887-917. PubMed ID: 38624681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does financial transparency substitute corporate governance to improve stock liquidity? Evidence from emerging market of Pakistan.
    Ali S; Zhongxin W; Ali Z; Usman M; Zhuoping Y
    Front Psychol; 2022; 13():1003081. PubMed ID: 36452385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 impact on firm investment-Evidence from Chinese publicly listed firms.
    Jiang J; Hou J; Wang C; Liu H
    J Asian Econ; 2021 Aug; 75():101320. PubMed ID: 36567767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can corporate social responsibility protect firm value during the COVID-19 pandemic?
    Qiu SC; Jiang J; Liu X; Chen MH; Yuan X
    Int J Hosp Manag; 2021 Feb; 93():102759. PubMed ID: 36919172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of ESG performance during times of COVID-19 pandemic.
    Gao M; Geng X
    Sci Rep; 2024 Jan; 14(1):2553. PubMed ID: 38297089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does institutional quality moderate the relationship between corporate governance and stock liquidity? Evidence from the emerging market of Pakistan.
    Ali S; Zhongxin W; Ali Z; Fei G; Chowdhury MAS
    Front Psychol; 2022; 13():912796. PubMed ID: 36211924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pandemic effect on corporate financial asset holdings: Precautionary or return-chasing?
    Gao H; Wen H; Wang X
    Res Int Bus Finance; 2022 Dec; 62():101750. PubMed ID: 35996462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managerial overconfidence in capital structure decisions and its link to aggregate demand: An agent-based model perspective.
    Rzeszutek M; Godin A; Szyszka A; Augier S
    PLoS One; 2021; 16(8):e0255537. PubMed ID: 34411130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brand equity and the Covid-19 stock market crash: Evidence from U.S. listed firms.
    Huang Y; Yang S; Zhu Q
    Financ Res Lett; 2021 Nov; 43():101941. PubMed ID: 36568952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.